Navigation Links
Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists
Date:3/26/2008

CHICAGO, March 26 /PRNewswire/ -- Thomas W. Burke, MD, Executive Vice President and Physician-in-Chief at The University of Texas M.D. Anderson Cancer Center, has been elected the 40th President of the Society of Gynecologic Oncologists (SGO) at the organization's 39th Annual Meeting, held March 9-12, 2008 in Tampa, Florida.

Dr. Burke received his undergraduate and medical degrees from Tulane University in New Orleans, Louisiana. He served both his internship and residency in Obstetrics/Gynecology at Tripler Army Medical Center in Honolulu, Hawaii, followed by a two-year fellowship in Gynecologic Oncology at Walter Reed Army Medical Center/Bethesda Naval Medical Center in Washington, DC.

Joining M.D. Anderson in 1988, Dr. Burke is responsible for oversight and strategic planning for patient care delivery throughout the hospital, clinics and outreach programs. Committed to clinical excellence, Dr. Burke's major goal is to enhance patient services through increased efficiency of human, fiscal and space resources.

A noted clinical researcher, Dr. Burke's focus has been on vulvar and endometrial cancers. His work has been instrumental in developing conservative surgical options for women with vulvar cancer, including lymphatic mapping, surgical reconstruction and combined modality therapy for advance tumors. His interest in uterine cancers has involved surgical staging procedures, adjuvant chemotherapy, treatment of recurrent disease and management of high-risk groups; and he currently leads M.D. Anderson's Uterine Cancer SPORE grant team.

Dr. Burke has written and contributed to chapters on vulvar and endometrial cancers for several textbooks and has authored and co-authored more than 130 original medical articles. He is a reviewer and editorial board member for several medical journals including Gynecologic Oncology, Cancer, Annual of Surgical Oncology, American Journal of Obstetrics and Gynecology and Lancet among others. In addition to SGO, Dr. Burke is also a member of the American College of Obstetricians and Gynecologists, the American College of Surgeons, the Felix Rutledge Society and the American Society of Clinical Oncology. He has been recognized not only for his clinical and educational activities but also for his national and international presentations on gynecologic cancers, and has received several teaching awards and nominations to Woodward and White's "Best Doctors in America" and Good Housekeeping's "Best Doctor's for Women." In addition, Dr. Burke is Board Certified by American Board of Obstetrics and Gynecology.

"As the 40th SGO president," said Dr. Burke of his appointment," I am looking forward to working with the Society's leadership and membership to set the strategic objectives that will guide the organization thru the next four decades of service to gynecologic oncologists and the patients we treat. With the enormous amount of treatment and preventative advances in gynecologic cancers, it is an extremely exciting time to serve as president of the leading Society representing the profession."

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at http://www.sgo.org.

For more information please contact:

Susan Morris

Society of Gynecologic Oncologists

Phone: 312/235-4060 x 244

Fax: 312/235-4059

Email: susan.morris@sgo.org


'/>"/>
SOURCE Society of Gynecologic Oncologists
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
3. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
5. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
6. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
7. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
8. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
10. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
11. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... February 19, 2017 , ... Expanding Portfolio to Include Lab ... equipment with the goal of expanding the reach of its quality and precision ... water analysis meters were introduced into the market in 2014. , The OHAUS ...
(Date:2/17/2017)... PUNE, India , February 17, 2017 /PRNewswire/ ... research report "Biomarkers Market by Product (Consumables, Service), ... Disorders), Application (Diagnostics Development, Drug Discovery and Development, ... MarketsandMarkets, the market is projected to reach USD ... in 2016, growing at a CAGR of 13.8% ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has launched work ... agricultural industry. Pilot studies are about to get under way for the framework, which ... 5G innovations. The concept is expected to be transferred eventually to other industries that ...
(Date:2/16/2017)... Calif. , Feb. 16, 2017  ArmaGen, ... developing groundbreaking therapies to treat severe neurological disorders, ... children treated with AGT-181, the company,s investigational therapy ... (also known as mucopolysaccharidosis type I, or MPS ... 2 proof-of-concept (POC) study, presented today at the ...
Breaking Biology Technology:
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/26/2017)... 26, 2017  Crossmatch, a leading provider of security ... aimed at combatting fraud, waste and abuse in assistance ... the Action on Disaster Relief conference in ... UN agencies and foreign assistance organizations throughout ... abuse are a largely unacknowledged problem in the foreign ...
Breaking Biology News(10 mins):